News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Calvin Sandra
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| Calvin Sandra (SVP, Chief Accounting Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 905 shares
@ $21.9044, valued at
$19.8k
Sold 192 shares
@ $21.63, valued at
$4.2k
|
|
| 09/15/2022 |
4
| Calvin Sandra (SVP, Chief Accounting Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 349 shares
@ $28, valued at
$9.8k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Calvin Sandra (VP, Corp Controller and CAO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 8,750 shares
@ $0
Sold 798 shares
@ $26.5059, valued at
$21.2k
Granted 17,500 options to buy
@ $27.5, valued at
$481.3k
|
|
| 01/26/2022 |
4
| Calvin Sandra (VP, Corp Controller and CAO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 934 shares
@ $24.5767, valued at
$23k
|
|
| 09/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|